Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.29 is 21% above its 5-year average of 3.55, around the middle of its 5-year range (1.57–6.83).
As of the fiscal period ended Tuesday, June 30, 2026. 13.53% below its 12-month average of 4.97.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.29.
CURRENT RATIO
4.29
CURRENT RATIO AVG TTM
4.97
CURRENT RATIO AVG 3Y
4.27
CURRENT RATIO AVG 5Y
3.55
CURRENT RATIO AVG 10Y
4.23
CURRENT RATIO AVG 15Y
4.65
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-13.53%
CURRENT VS 3Y AVG
+0.66%
CURRENT VS 5Y AVG
+20.87%
CURRENT VS 10Y AVG
+1.62%
CURRENT VS 15Y AVG
-7.71%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+14.53%
vs the sector median at left
Market Cap
$58.16M
Current Ratio
0.57
TTM Avg
2.81
3Y Avg
4.44
5Y Avg
7.47
Market Cap
$59.05M
Current Ratio
2.37
TTM Avg
7.60
3Y Avg
7.51
5Y Avg
12.19
Market Cap
$54.50M
Current Ratio
1.14
TTM Avg
1.23
3Y Avg
1.31
5Y Avg
1.31
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Talphera, Inc. (TLPH) | $57.35M | 4.29 | 4.97 | 4.27 | 3.55 |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | 2.43 | 1.42 | 0.94 | 1.84 |
| PDS Biotechnology Corporation (PDSB)vs › | $58.16M | 0.57 | 2.81 | 4.44 | 7.47 |
| MiNK Therapeutics, Inc. (INKT)vs › | $57.69M | 1.23 | 0.89 | 0.93 | 1.06 |
| Boundless Bio, Inc. (BOLD)vs › | $57.98M | 9.48 | 13.86 | 12.45 | 13.81 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $59.05M | 2.37 | 7.60 | 7.51 | 12.19 |
| Adicet Bio, Inc. (ACET)vs › | $59.78M | 6.71 | 8.38 | 9.61 | 10.03 |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $54.50M | 1.14 | 1.23 | 1.31 | 1.31 |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | 1.35 | 1.97 | 5.50 | 8.52 |
| Spectral AI, Inc. (MDAI)vs › | $53.62M | 0.90 | 0.75 | 1.27 | 1.79 |
Current Ratio
4.29
Quick Ratio
4.29
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.29 |
| 2026-03-31 | 5.30 |
| 2025-12-31 | 5.49 |
| 2025-09-30 | 6.83 |
| 2025-06-30 | 2.93 |
| 2025-03-31 | 3.11 |
| 2024-12-31 | 3.56 |
| 2024-09-30 | 4.42 |
| 2024-06-30 | 4.90 |
| 2024-03-31 | 5.97 |
| 2023-12-31 | 2.56 |
| 2023-09-30 | 4.04 |
| 2023-06-30 | 2.09 |
| 2023-03-31 | 1.83 |
| 2022-12-31 | 1.78 |
| 2022-09-30 | 1.57 |
| 2022-06-30 | 1.81 |
| 2022-03-31 | 2.51 |
| 2021-12-31 | 2.73 |
| 2021-09-30 | 3.03 |
| 2021-06-30 | 3.88 |
| 2021-03-31 | 4.59 |
| 2020-12-31 | 2.66 |
| 2020-09-30 | 2.89 |
| 2020-06-30 | 2.96 |
| 2020-03-31 | 3.69 |
| 2019-12-31 | 5.27 |
| 2019-09-30 | 7.49 |
| 2019-06-30 | 11.69 |
| 2019-03-31 | 5.03 |
| 2018-12-31 | 6.78 |
| 2018-09-30 | 4.56 |
| 2018-06-30 | 4.01 |
| 2018-03-31 | 4.05 |
| 2017-12-31 | 4.64 |
| 2017-09-30 | 4.78 |
| 2017-06-30 | 4.92 |
| 2017-03-31 | 6.11 |
| 2016-12-31 | 8.74 |
| 2016-09-30 | 6.24 |
| 2016-06-30 | 5.02 |
| 2016-03-31 | 6.71 |
| 2015-12-31 | 9.31 |
| 2015-09-30 | 15.55 |
| 2015-06-30 | 4.02 |
| 2015-03-31 | 4.26 |
| 2014-12-31 | 5.56 |
| 2014-09-30 | 8.36 |
| 2014-06-30 | 10.67 |
| 2014-03-31 | 20.39 |
| 2013-12-31 | 15.22 |
| 2013-09-30 | 6.20 |
| 2013-06-30 | 2.91 |
| 2013-03-31 | 3.36 |
| 2012-12-31 | 4.31 |
| 2012-09-30 | 2.07 |
| 2012-06-30 | 3.15 |
| 2012-03-31 | 3.47 |
| 2011-12-31 | 4.86 |
| 2011-09-30 | 6.69 |
| 2011-06-30 | 10.33 |
| 2011-03-31 | 6.38 |
| 2010-12-31 | 0.43 |
| 2010-09-30 | 1.46 |
| 2010-06-30 | 0.00 |
| 2010-03-31 | 0.00 |
| 2009-12-31 | 2.15 |
